Valsts: Īrija
Valoda: angļu
Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)
CLINDAMYCIN (AS CLINDAMYCIN HYDROCHLORIDE)
Chanelle Animal Health Ltd.
QJ01FF01
CLINDAMYCIN (AS CLINDAMYCIN HYDROCHLORIDE)
75 Milligram
Capsule
POM
Canine
Clindamycin
Antibacterial
Authorised
2013-06-28
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Clindaseptin 75 mg capsules for dogs. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains: ACTIVE SUBSTANCE: Clindamycin (as Clindamycin Hydrochloride) 75 mg. EXCIPIENTS: For the full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Capsule. The capsule has a lavender body and a lavender cap marked CL75. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of:- Infected wounds, abscesses and oral cavity/dental infections caused by or associated with clindamycin-sensitive species of; _Staphylococcus_ _Streptococcus_ _Bacteroides_ _Fusobacterium necrophorum_ _Clostridium perfringens_ Osteomyelitis _Staphylococcus aureus_ 4.3 CONTRAINDICATIONS Do not use in cases of known hypersensitivity to clindamycin, lincomycin or pirlimycin. Do not administer to rabbits, hamsters, guinea pigs, chinchillas, horses or ruminants because ingestion of clindamycin by these species may result in severe gastro-intestinal disturbance. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None known. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 08/11/2016_ _CRN 7024937_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS During prolonged therapy of one month or greater, periodic liver and kidney function tests and blood counts should be performed. Patients with severe renal and/or hepatic disturbances accompanied by severe metabolic aberrations should be dosed with caution and should be monitored by serum examination during clindamycin therapy. Whenever possible, the veterinary medicinal product should only be used based on susceptibility t Izlasiet visu dokumentu